Natural catalytic antibodies in norm, autoimmune, viral, and bacterial diseases

TheScientificWorldJournal

Volumn 10, Issue , 2010, Pages 1203-1233

  Nevinsky, Georgy A ^a   Buneva, Valentina N ^a  

^a INSTITUTE OF CHEMICAL BIOLOGY AND FUNDAMENTAL MEDICINE   (Russian Federation)

Author keywords

Autoimmune; Bacterial diseases; Healthy donors; Natural abzymes; Viral

Indexed keywords

ADENOSINE TRIPHOSPHATASE; AMYLASE; ANTIGEN; AUTOANTIBODY; BLOOD CLOTTING FACTOR 8; CARDIOLIPIN; CATALYTIC ANTIBODY; CONCANAVALIN A; DEOXYRIBONUCLEASE; DNA; DNA ANTIBODY; EDETIC ACID; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTEGRASE; IODOACETAMIDE; LEUPEPTIN; MONOCLONAL ANTIBODY; MYELIN BASIC PROTEIN; PEPSTATIN; POLYCLONAL ANTIBODY; PROTEINASE INHIBITOR; PROTHROMBIN; RIBONUCLEASE; RNA; RNA DIRECTED DNA POLYMERASE; THYROGLOBULIN; VASOACTIVE INTESTINAL POLYPEPTIDE; VIRUS ENZYME;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIBODY RESPONSE; ANTIGEN ANTIBODY COMPLEX; ASTHMA; AUTOIMMUNE DISEASE; AUTOIMMUNE HEPATITIS; BACTERIAL INFECTION; BONE MARROW; BURST FORMING UNIT E; CATALYSIS; CELL PROLIFERATION; COLONY FORMING UNIT GEMM; COLONY FORMING UNIT GM; CYTOTOXICITY; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME SPECIFICITY; ENZYME SUBSTRATE; GENETIC PREDISPOSITION; HASHIMOTO DISEASE; HEMATOPOIETIC STEM CELL; HEMOPHILIA A; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HYDROLYSIS; IMMUNIZATION; IMMUNOREGULATION; LYMPH NODE; LYMPHOCYTE DIFFERENTIATION; MULTIPLE MYELOMA; MULTIPLE SCLEROSIS; MYASTHENIA GRAVIS; NONHUMAN; PROTEIN DEGRADATION; RHEUMATOID ARTHRITIS; SHORT SURVEY; SJOEGREN SYNDROME; SPLEEN; SYSTEMIC LUPUS ERYTHEMATOSUS; THYMUS; VIRUS HEPATITIS; VIRUS INFECTION; IMMUNOLOGY; REFERENCE VALUE; REVIEW;

BACTERIA (MICROORGANISMS); MAMMALIA;

ANTIBODIES, CATALYTIC; AUTOIMMUNE DISEASES; BACTERIAL INFECTIONS; HUMANS; REFERENCE VALUES; VIRUS DISEASES;

EID: 77955915554     PISSN: None     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1100/tsw.2010.98     Document Type: Short Survey

References (168)

1. Pauling, L. (1946) Molecular basis of biological specificity. Chem. Eng. News 24, 1375-1377.
2. Pollack, S.J., Jacobs, J.W., and Schultz, P.G. (1986) Selective chemical catalysis by an antibody. Science 234, 1570-1573.
3. Tramontano, A., Janda, K.D., and Lerner, R.A. (1986a) Catalytic antibodies. Science 234, 1566-1570.
4. Tramontano, A., Janda, K.D., and Lerner, R.A. (1986b) Chemical reactivity at an antibody binding site elicited by mechanistic design of a synthetic antigen. Proc. Natl. Acad. Sci. U. S. A. 83, 6736-6740.
5. Lerner, R.A. and Tramontano, A. (1987) Antibodies as enzymes. Trends Biochem. Sci. 12, 427-438.
6. Stewart, J.D. and Benkovic, S.J. (1993) Recent developments in catalytic antibodies. Int. Rev. Immunol. 10, 229 240.
7. Martin, A.B. and Schultz, P.G. (1999) Opportunities at the interface of chemistry and biology. Trends Cell Biol. 9, 24-28.
8. Nevinsky, G.A., Semenov, D.V., and Buneva, V.N. (2000) Catalytic antibodies (abzymes) induced by stable transition-state analogs. Biochemistry (Mosc.) 65, 1233-1244.
9. Tanaka, F. (2002) Catalytic antibodies as designer proteases and esterases. Chem. Rev. 102, 4885-4906.
10. Deng, S.X., de Prada, P., and Landry, D.W. (2002) Anticocaine catalytic antibodies. J. Immunol. Methods 269, 299-310.
11. Dias, S., Jovic, F., Renard, P.Y., Taran, F., Créminon, C., Mioskowski, C., and Grassi, J. (2002) Immunologically driven chemical engineering of antibodies for catalytic activity. J. Immunol. Methods 269, 81-98.
12. Tanaka, F. and Barbas, C.F., 3rd (2002) Reactive immunization: a unique approach to catalytic antibodies. J. Immunol. Methods 269, 67-79.
13. Keinan, E., Ed. (2005) Catalytic Antibodies. Wiley-VCH Verlag, Weinheim.
14. Iverson, B.L. and Lerner, R.A. (1989) Sequence-specific peptide cleavage catalyzed by an antibody. Science 243, 1184-1188.
15. Barbas, C.F., 3rd, Heine, A., Zhong, G., Hoffmann, T., Gramatikova, S., Bjornestedt, R., List, B., Anderson, J., Stura, E.A., Wilson, I.A., and Lerner, R.A. (1997) Immune versus natural selection: antibody aldolases with enzymic rates but broader scope. Science 278, 2085-2092. (Pubitemid 28028312)
16. Gouverneur, V.E., Houk, K.N., de Pascual-Teresa, B., Beno, B., Janda, K.D., and Lerner, R.A. (1993) Control of the exo and endo pathways of the Diels-Alder reaction by antibody catalysis. Science 262, 204-208. (Pubitemid 23344463)
17. Janda, K.D., Lo, L.C., Lo, C.H., Sim, M.M., Wang, R., Wong, C.H., and Lerner, R.A. (1997) Chemical selection for catalysis in combinatorial antibody libraries. Science 275, 945-948. (Pubitemid 27087703)
18. Thayer, M.M., Olender, E.H., Arvai, A.S., Koike, C.K., Canestrelli, I.L., Stewart, J.D., Benkovic, S.J., Getzoff, E.D., and Roberts, V.A. (1999) Structural basis for amide hydrolysis catalyzed by the 43C9 antibody. J. Mol. Biol. 291, 329-345.
19. Paul, S., Volle, D.J., Beach, C.M., Johnson, D.R., Powell, M.J., and Massey, R.J. (1989) Catalytic hydrolysis of vasoactive intestinal peptide by human autoantibody. Science 244, 1158-1162. (Pubitemid 19170484)
20. Shuster, A.M., Gololobov, G.V., Kvashuk, O.A., Bogomolova, A.E., Smirnov, I.V., and Gabibov, A.G. (1992) DNA hydrolyzing autoantibodies. Science 256, 665-667.
21. Buneva, V.N., Andrievskaia, O.A., Romannikova, I.V., Gololobov, G.V., Iadav, R.P., Iamkovoi, V.I., and Nevinskii, G.A. (1994) Interaction of catalytically active antibodies with oligoribonucleotides. Mol. Biol. (Mosk.) 28, 738-743.
22. Suzuki, H. (1994) Recent advances in abzyme studies. J. Biochem. 115, 623-633.
23. Tramontano, A., Gololobov, G., and Paul, S. (2000) Proteolytic antibodies: origins, selection and induction. Chem. Immunol. 77, 1-17.
24. Gololobov, G., Tramontano, A., and Paul, S. (2000) Nucleophilic proteolytic antibodies. Appl. Biochem. Biotechnol. 83, 221-231.
25. Nevinsky, G.A., Kanyshkova, T.G., and Buneva, V.N. (2000) Natural catalytic antibodies (abzymes) in normalcy and pathology. Biochemistry (Mosc.) 65, 1245-1255.
26. Nevinsky, G.A. and Buneva, V.N. (2002) Human catalytic RNA- and DNA-hydrolyzing antibodies. J. Immunol. Methods 269, 235-245.
27. Nevinsky, G.A., Favorova, O.O., and Buneva, V.N. (2002) Natural catalytic antibodies - new characters in the protein repertoire. In Protein-Protein Interactions; a Molecular Cloning Manual. Golemis, E., Ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY. pp. 532-534.
28. Nevinsky, G.A. and Buneva, V.N. (2003) Catalytic antibodies in healthy humans and patients with autoimmune and viral pathologies. J. Cell. Mol. Med. 7, 265-276.
29. Nevinsky, G.A. and Buneva, V.N. (2005) Natural catalytic antibodies-abzymes. In Catalytic Antibodies. Keinan, E., Ed. Wiley-VCH Verlag, Weinheim. pp. 503-567.
30. Kalaga, R., Li, L., O'Dell, J.R., and Paul, S. (1995) Unexpected presence of polyreactive catalytic antibodies in IgG from unimmunized donors and decreased levels in rheumatoid arthritis. J. Immunol. 155, 2695-2702.
31. Thiagarajan, P., Dannenbring, R., Matsuura, K., Tramontano, A., Gololobov, G., and Paul, S. (2000) Monoclonal antibody light chain with prothrombinase activity. Biochemistry 39, 6459-6465. (Pubitemid 30347151)
32. Lacroix-Desmazes, S., Moreau, A., Sooryanarayana, Bonnemain, C., Stieltjes, N., Pashov, A., Sultan, Y., Hoebeke, J., Kazatchkine, M.D., and Kaveri, S.V. (1999) Catalytic activity of antibodies against factor VIII in patients with hemophilia A. Nat. Med. 5, 1044-1047.
33. Polosukhina, D.I., Kanyshkova, T., Doronin, B.M., Tyshkevich, O.B., Buneva, V.N., Boiko, A.N., Gusev, E.I., Favorova, O.O., and Nevinsky, G.A. (2004) Hydrolysis of myelin basic protein by polyclonal catalytic IgGs from the sera of patients with multiple sclerosis. J. Cell. Mol. Med. 8, 359-368.
34. Polosukhina, D.I., Buneva, V.N., Doronin, B.M., Tyshkevich, O.B., Boiko, A.N., Gusev, E.I., Favorova, O.O., and Nevinsky, G.A. (2005) Hydrolysis of myelin basic protein by IgM and IgA antibodies from the sera of patients with multiple sclerosis. Med. Sci. Monit. 11, BR266-BR272.
35. Polosukhina, D.I., Kanyshkova, T.G., Doronin, B.M., Tyshkevich, O.B., Buneva, V.N., Boiko, A.N., Gusev, E.I., Favorova, O.O., and Nevinsky, G.A. (2006) Metal-dependent hydrolysis of myelin basic protein by IgGs from the sera of patients with multiple sclerosis. Immunol. Lett. 103, 75-81.
36. Odintsova, E.S., Kharitonova, M.A., Baranovskii, A.G., Siziakina, L.P., Buneva, V.N., and Nevinsky, G.A. (2006) Proteolytic activity of IgG antibodies from blood of acquired immunodeficiency syndrome patients. Biochemistry (Mosc.) 71, 251-261.
37. Baranova, S.V., Buneva, V.N., Kharitonova, M.A., Sizyakina, L.P., Calmels, C., Andreola, M.L., Parissi, V., and Nevinsky, G.A. (2009) HIV-1 integrase-hydrolyzing antibodies from sera of HIV-infected patients. Biochimie 91, 1081-1086.
38. Zouali, M. (2001) B cell tolerance to self in systemic autoimmunity. Arch. Immunol. Ther. Exp. (Warsz.) 49, 361-365.
39. Pisetsky, D. (2001) Immune response to DNA in systemic lupus erythematosus. Isr. Med. Assoc. J. 3, 850-853.
40. Earnshaw, W.C. and Rothfield, N. (1985) Identification of a family of human centromere proteins using autoimmune sera from patients with scleroderma. Chromosoma 91, 313-321.
41. Raptis, L. and Menard, H.A. (1980) Quantitation and characterization of plasma DNA in normals and patients with systemic lupus erythematosus. J. Clin. Invest. 66, 1391-1399.
42. Reimer, C., Raska, I., Tan, E.M., and Sheer, U. (1987) Human autoantibodies: probes for nucleolus structure and function. Virchows Arch. B Cell Pathol. Incl. Mol. Pathol. 54, 131-143.
43. Hhachn, B.Ch. (1996) Systemic lipus erythematosus. In Internal Diseases. Braunvald, E.E. et al., Eds. Medicine, Moscow. pp. 407-419.
44. Jager, L. (1988) Klinishe immunologie and allergologie. Vol. 3. VEB Gustav Fischer Verlag, Stuttgart. pp. 270-279.
45. Shoenfeld, Y., Ben-Yehuda, O., Messinger, Y., Bentwitch, Z., Rauch, J., Isenberg, D.I., and Gadoth, N. (1988) Autoimmune diseases other than lupus share common anti-DNA idiotypes. Immunol. Lett. 17, 285-291.
46. Shoenfeld, Y., Teplizki, H.A., Mendlovic, S., Blank, M., Mozes, E., and Isenberg, D.A. (1989) The role of the human anti-DNA idiotype 16/6 in autoimmunity. Clin. Immunol. Immunopathol. 51, 313-325.
47. Kozyr, A.V., Kolesnikov, A.V., Aleksandrova, E.S., Sashchenko, L.P., Gnuchev, N.V., Favorov, P.V., Kotelnikov, M.A., Iakhnina, E.I., Astsaturov, I.A., Prokaeva, T.B., Alekberova, Z.S., Suchkov, S.V., and Gabibov, A.G. (1998) Novel functional activities of anti-DNA autoantibodies from sera of patients with lymphoproliferative and autoimmune diseases. Appl. Biochem. Biotechnol. 75, 45-61.
48. Gololobov, G.V., Mikhalap, S.V., Starov, A.V., Kolesnikov, A.F., and Gabibov, A.G. (1994) DNA-protein complexes. Natural targets for DNA-hydrolyzing antibodies. Appl. Biochem. Biotechnol. 47, 305-314.
49. Blanco, F., Kalsi, J., and Isenberg, D.A. (1991) Analysis of antibodies to RNA in patients with systemic lupus erythematosus and other autoimmune rheumatic diseases. Clin. Exp. Immunol. 86, 66-70.
50. Sato, T., Uvhiumi, T., Arakawa, M., and Kominami, R. (1994) Serological association of lupus autoantibodies to a limited functional domain of 28S ribosomal RNA and to the ribosomal proteins bound to the domain. Clin. Exp. Immunol. 98, 35-39.
51. Hirokawa, K., Takasaki, Y., Takeuchi, K., Kaneda, K., Ikeda, K., Hashimoto, H., and Ikeda, R. (2002) Anti-TS1- RNA: characterization of novel antibodies against sequence-specific RNA by random RNA selection in patients with Sjogren's syndrome. J. Rheumatol. 29, 931-937. (Pubitemid 34493495)
52. Ikeda, R., Takasaki, Y., Hirokawa, K., Takeuchi, K., and Hashimoto, H. (2003) Clinical significance of antibodies to TS1-RNA in patients with mixed connective tissue disease. J. Rheumatol. 30, 998-1005. (Pubitemid 36529620)
53. Korovkina, E.S., Zonova, E.V., Buneva, V.N., Konenkova, L.P., and Nevinsky, G.A. (2006) Interdependency analysis between antibody level to different antigenes and clinical data of systemic lupus erythematosus. Allergol. Immunol. (Russ.) 7, 498-507.
54. O-onnor, K.C., Bar-Or, A., and Hafler, D.A. (2001) Neuroimmunology of multiple sclerosis. J. Clin. Immunol. 21, 81-92.
55. Archelos, J.J., Storch, M.K., and Hartung, H.P. (2000) The role of B cells and autoantibodies in multiple sclerosis. Ann. Neurol. 47, 694-706.
56. Hemmer, B., Archelos, J.J., and Hartung, H.P. (2002) New concepts in the immunopathogenesis of multiple sclerosis. Nat. Rev. Neurosci. 3, 291-301.
57. Williamson, R.A., Burgoon, M.P., Owens, G.P., Ghausi, O., Leclerc, E., Firme, L., Carlson, S., Corboy, J., Parren, P.W., Sanna, P.P., Gilden, D.H., and Burton, D.R. (2001) Anti-DNA antibodies are a major component of the intrathecal B cell response in multiple sclerosis. Proc. Natl. Acad. Sci. U. S. A. 98, 1793-1798.
58. Ershova, N.A., Garmashova, N.V., Buneva, V.N., Mogel-itskii, A.S., Tyshkevich, O.B., Doronin, B.M., Konenkova, L.P., Boiko, A.N., Slanova, A.V., Nesterova, V.A., Gusev, E.I., Favorova, O.O., and Nevinskii, G.A. (2003) Association between DNA antibodies levels in the blood of patients with multiple sclerosis and clinical presentation of the disease. Zh. Nevrol. Psikhiatr. Im. S. S. Korsakova (Russ.) 2, 25-33.
59. Ershova, N.A., Garmashova, N.V., Mogel-itskii, A.S., Tyshkevich, O.B., Doronin, B.M., Konenkova, L.P., Buneva, V.N., and Nevinskii, G.A. (2007) Antibodies to DNA in the blood of patients with multiple sclerosis. Russ. J. Immunol. 1, 229-245.
60. Polosukhina, D.I., Garmashova, N.V., Tyshkevich, O.B., Doronin, B.M., Buneva, V.N., and Nevinskii, G.A. (2009) Autoantibodies to myelin basic protein in patients with multiple sclerosis. Int. J. Immunorehabilitat. (Russ.) 11, 10-18.
61. Poser, C.M. (1984) The Diagnosis of Multiple Sclerosis. Thieme-Stratton, New York. pp. 3-13.
62. Boger, U., Hegedus, L., Hansen, J.M., Finke, R., and Shleusener, H. (1995) Thyroid cytotoxic antibodies in atrophic and goiters autoimmune thyroiditis. Eur. J. Endocrinol. 132, 69-74.
63. Michels, A.W. and Eisenbarth, G.S. (2010) Immunologic endocrine disorders. J. Allergy Clin. Immunol. 125, S226-S237.
64. Engler, H., Riesen, W.F., and Keller, B. (1994) Anti-thyroid peroxidase (anti-TPO) antibodies in thyroid diseases, non-thyroidal illness and controls. Clinical validity of a new commercial method for detection of anti-TPO (thyroid microsomal) autoantibodies. Clin. Chem. Acta 225, 123-136.
65. Senda, Y., Nishibu, M., Kawai, K., Mizukami, Y., and Hashimoto, T. (1995) Estimation of anti-thyroid peroxidase autoantibody and anti-thyroglobulin autoantibody in patients with various thyroid disease - comparison between histopathological findings and serological results in patients with Hashimoto's thyroiditis. Rinsho-Byori 43, 1243-1250.
66. Garmashova, N.V., Kazanskii, V.E., Tyshkevich, O.B., Doronin, B.M., Buneva, V.N., and Nevinskii, G.A. (2004) Antibodies to DNA in the blood of patients with tick-borne encephalitis. Mol. Biol. (Mosk.) 38, 723-730.
67. Fauci, A.S., Braunwald, E., Kasper, D.L., et al. (2008) Harrison's Principles of Internal Medicine. 17th ed. McGraw-Hill Professional, New York.
68. Matsiota-Bernard, P., Mahana, W., Avrameas, S., and Nauciel, C. (1993) Specific and natural antibody production during Salmonella typhimurium infection in genetically susceptible and resistant mice. Immunology 79, 375-380. (Pubitemid 23196113)
69. Matsiota-Bernard, P., Hentati, B., Pie, S., Legakis, N., Nauciel, C., and Avrameas, S. (1996) Beneficial effect of Salmonella typhimurium infection and of immunoglobulins from S. typhimurium-infected mice on the autoimmune disease of (NZB x NZW) F1 mice. Clin. Exp. Immunol. 104, 228-235.
70. Hentati, B., Sato, M.N., Payelle, B., Avrameas, S., and Ternynck, T. (1994) Beneficial effect of polyclonal immunoglobulins from malaria-infected BALB/c mice on the lupus-like syndrome of (NZB x NZW)F1 mice. Eur. J. Immunol. 24, 8-15.
71. Ternynck, P., Falanga, B., Unterkircher, C., Gregoire, J., Da Silva, L.P., and Avrameas, S. (1991) Induction of high levels of IgG autoantibodies in mice infected with Plasmodium chabaudi. Int. Immunol. 3, 29-37.
72. Boekel, E.T., Siegert, C.E., Vrielink, G.J., Ceelen, A., and De Kievet, W. (2007) Analyses of CD27(++) plasma cells in peripheral blood from patients with bacterial infections and patients with serum antinuclear antibodies. J. Clin. Immunol. 27, 467-476.
73. Wun, H.L., Leung, D.T., Wong, K.C., Chui, Y.L., and Lim, P.L. (2001) Molecular mimicry: anti-DNA antibodies may arise inadvertently as a response to antibodies generated to microorganisms. Int. Immunol. 13, 1099-1107.
74. Steinman, L. (2001) Multiple sclerosis: a two-stage disease. Nat. Immunol. 2, 2762-2764.
75. Berneman, A., Cuilbert, B., Enschrich, S., and Avrames, S. (1993) IgG auto- and polyreactivities of normal human sera. Mol. Immunol. 30, 1499-1510.
76. Coutinho, A., Kazatchkine, M.D., and Avrameas, S. (1995) Natural autoantibodies. Curr. Opin. Immunol. 7, 812-818.
77. Buneva, V.N., Kudryavtseva, A.N., Gal'vita, A.V., Dubrovskaya, V.V., Khokhlova, O.V., Kalinina, I.A., Galenok, V.A., and Nevinsky, G.A. (2003) Dynamics of antibody nuclease activity in blood of women during pregnancy and lactation. Biochemistry (Mosc.) 68, 890-900.
78. Parkhomenko, T.A., Buneva, V.N., Tyshkevich, O.B., Generalov, I.I., Doronin, B.M., and Nevinsky, G.A. (2010) DNA-hydrolyzing activity of IgG antibodies from the sera of patients with tick-borne encephalitis. Biochimie 92, 545-554.
79. Odintsova, E.S., Parkhomanko, T.A., Buneva, V.N., Generalov, I.I., and Nevinsky, G.A. (2006) IgG antibodies from the sera of patients with some infectional diseases. Immunopathol. Allergol. Infectol. (Russ.) 2, 23-31.
80. Wentworth, P., Jr., Liu, Y., Wentworth, A.D., Fan, P., Foley, M.J., and Janda, K.D. (1998) A bait and switch hapten strategy generates catalytic antibodies for phosphodiester hydrolysis. Proc. Natl. Acad. Sci. U. S. A. 95, 5971-5975.
81. Izadyar, L., Friboulet, A., Remy, M.H., Roseto, A., and Thomas, D. (1993) Monoclonal anti-idiotypic antibodies as functional internal images of enzyme active sites: production of a catalytic antibody with a cholinesterase activity. Proc. Natl. Acad. Sci. U. S. A. 90, 8876-8880.
82. Kolesnikov, A.V., Kozyr, A.V., Alexandrova, E.S., Koralewski, F., Demin, A.V., Titov, M.I., Avalle, B., Tramontano, A., Paul, S., Thomas, D., Gabibov, AG., and Friboulet, A. (2000) Enzyme mimicry by the antiidiotypic antibody approach. Proc. Natl. Acad. Sci. U. S. A. 97, 13526-13531.
83. Hu, R., Xie, G.Y., Zhang, X., Guo, Z.Q., and Jin, S. (1998) Production and characterization of monoclonal antiidiotypic antibody exhibiting a catalytic activity similar to carboxypeptidase A. J. Biotechnol. 61, 109-115. (Pubitemid 28269320)
84. Friboulet, A., Izadyar, L., Avalle, B., Roseto, A., and Thomas, D. (1994) Abzyme generation using an anti-idiotypic antibody as the "internal image" of an enzyme active site. Appl. Biochem. Biotechnol. 47, 229-237.
85. Debat, H., Avalle, B., Chose, O., Sarde, C.-O., Friboulet, A., and Thomas, D. (2001) Overpassing an aberrant V(kappa) gene to sequence an anti-idiotypic abzyme with (beta)-lactamase-like activity that could have a linkage with autoimmune diseases. FASEB J. 15, 815-822. (Pubitemid 32246000)
86. Hifumi, E., Morihara, F., Hatiuchi, K., Okuda, T., Nishizono, A., and Uda, T. (2008) Catalytic features and eradication ability of antibody light-chain UA15-L against Helicobacter pylori. J. Biol. Chem. 283, 899-907.
87. Odintsova, E.S., Buneva, V.N., and Nevinsky, G.A. (2005) Casein-hydrolyzing activity of sIgA antibodies from human milk. J. Mol. Recognit.18, 413-421.
88. Krasnorutskii, M.A., Buneva, V.N., and Nevinsky, G.A. (2008a) Antibodies against DNA hydrolyze DNA and RNA. Biochemistry (Mosc.) 73, 1547-1560.
89. Krasnorutskii, M.A., Buneva, V.N., and Nevinsky, G.A. (2008b) Antibodies against RNA hydrolyze RNA and DNA. J. Mol. Recognit. 21, 337-346.
90. Krasnorutskii, M.A., Buneva, V.N., and Nevinsky, G.A. (2008c) Immunization of rabbits with DNase I produces polyclonal antibodies with DNase and RNase activities. J. Mol. Recognit. 21, 233-242.
91. Krasnorutskii, M.A., Buneva, V.N., and Nevinsky, G.A. (2008d) Anti-RNase antibodies against pancreatic ribonuclease A hydrolyze RNA and DNA. Int. Immunol. 20, 1031-1040.
92. Krasnorutskii, M.A., Buneva, V.N., and Nevinsky, G.A. (2009) Immunization of rabbits with DNase II leads to formation of polyclonal antibodies with DNase and RNase activities. Int. Immunol. 21, 349-360.
93. Founel, S. and Muller, S. (2002) Antinucleosome antibodies and T-cell response in systemic lupus erythematosus. Ann. Med. Interne (Paris) 153, 513-519.
94. Nishi, Y. (2002) Evolution of catalytic antibody repertoire in autoimmune mice. J. Immunol. Methods 269, 213-233.
95. Tawfik, D.S., Chap, R., Green, B.S., Sela, M., and Eshhar, Z. (2002) Unexpectedly high occurrence of catalytic antibodies in MRL/lpr and SJL mice immunized with a transition-state analog: is there a linkage to autoimmunity? Proc. Natl. Acad. Sci. U. S. A. 92, 2145-2149.
96. Amino, N., Mori, H., Iwatani, Y., Tanizawa, O., Kawashima, M., Tsuge, I., Ibaragi, K., Kumahara, Y., and Miyai, K. (1982) High prevalence of transient post-partum thyrotoxicosis and hypothyroidism. N. Engl. J. Med. 306, 849-852.
97. Tanaka, A., Lindor, K., Ansari, A., and Gershwin, M.E. (2000) Fetal microchimerisms in the mother: immunologic implications. Liver Transpl. 6, 138-143. (Pubitemid 30173991)
98. Nagata, S. and Suda, T. (1995) Fas and Fas ligand: lpr and gld mutations. Immunol. Today 16, 39-43.
99. Watanabe-Fukunada, R., Brannan, C.I., and Copeland, N.G. (1992) Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356, 314-317.
100. Dubrovskaya, V.V., Andryushkova, A.S., Kuznetsova, I.A., Toporkova, L.B., Buneva, V.N., Orlovskaya, I.A., and Nevinsky, G.A. (2003) DNA-hydrolyzing antibodies from sera of autoimmune-prone MRL/MpJ-lpr mice. Biochemistry (Mosc.) 68, 1081-1088.
101. Andryushkova, A.A., Kuznetsova, I.A., Orlovskaya, I.A., Buneva, V.N., and Nevinsky, G.A. (2006) Antibodies with amylase activity from the sera of autoimmune-prone MRL/MpJ-lpr mice. FEBS Lett. 580, 5089-5095.
102. Andryushkova, A.S., Kuznetsova, I.A., Orlovskaya, I.A., Buneva, V.N., and Nevinsky, G.A. (2009) Nucleotide-hydrolyzing antibodies from the sera of autoimmune-prone MRL-lpr/lpr mice. Int. Immunol. 21, 935-945.
103. Andryushkova, A.S., Kuznetsova, I.A., Buneva, V.N., Toporkova, L.B., Sakhno, L.V., Tichonova, M.A., Chernykh, E.R., Orlovskaya, I.A., and Nevinsky, G.A. (2007) Formation of different abzymes in autoimmune-prone MRL-lpr/ lpr mice is associated with changes in colony formation of haematopoetic progenitors. J. Cell. Mol. Med. 11, 531-551.
104. Paul, S. (1998) Mechanism and functional role of antibody catalysis. Appl. Biochem. Biotechnol. 75, 13-24.
105. Ponomarenko, N.A., Durova, O.M., Vorobiev, I.I., Belogurov, A.A., Kurkova, I.N., Petrenko, A.G., Telegin, G.B., Suchkov, S.V., Kiselev, S.L., Lagarkova, M.A., Govorun, V.M., Serebryakova, M.V., Avalle, B., Tornatore, P., Karavanov, A., Thomas, D., Friboulet, A., and Gabibov, A.G. (2006) Autoantibodies to myelin basic protein catalyze site-specific degradation of their antigen. Proc. Natl. Acad. Sci. U. S. A. 103, 281-286.
106. Belogurov, A.A., Kurkova, I.N., Friboulet, A., Thomas, D., Misikov, V.K., Zakharova, M.Y., Suchkov, S.V., Kotov, S.V., Alehin, A.I., Avalle, B., Suslova, E.A., Morse, H.C., 3rd, Gabibov, A.G., and Ponomarenko, N.A. (2008) Recognition and degradation of myelin basic protein peptides by serum autoantibodies: novel biomarker for multiple sclerosis. J. Immunol. 180, 1258-1267.
107. Sinohara, H. and Matsuura, K. (2000) Does catalytic activity of Bence-Jones proteins contribute to the pathogenesis of multiple myeloma? Appl. Biochem. Biotechnol. 83, 85-94.
108. Nevinsky, G.A., Breusov, A.A., Baranovskii, A.G., Prints, A.V., Kanyshkova, T.G., Galvita, A.V., Naumov, V.A., and Buneva, V.N. (2001) Effect of different drugs on the level of DNA-hydrolyzing polyclonal IgG antibodies in sera of patients with Hashimoto? thyroiditis and nontoxic nodal goiter. Med. Sci. Monit. 7, 201-211.
109. Lacroix-Desmazes, S., Bayry, J., Kaveri, S.V., Hayon-Sonsino, D., Thorenoor, N., Charpentier, J., Luyt, C.E., Mira, J.P., Nagaraja, V., Kazatchkine, M.D., Dhainaut, J.F., and Mallet, V.O. (2005) High levels of catalytic antibodies correlate with favorable outcome in sepsis. Proc. Natl. Acad. Sci. U. S. A. 102, 4109-4113.
110. Li, L., Paul, S., Tyutyulkova, S., Kazatchkine, M.D., and Kaveri, S. (1995) Catalytic activity of anti-thyroglobulin antibodies. J. Immunol. 154, 3328-3332.
111. Odintsova, E.S., Kharitonova, M.A., Baranovskii, A.G., Siziakina, L.P., Buneva, V.N., and Nevinskii, G.A. (2006) DNA-hydrolyzing IgG antibodies from the blood of patients with acquired immune deficiency syndrome. Mol. Biol. (Mosk.) 40, 857-864.
112. Wentworth, P., Jr., Jones, L.H., Wentworth, A.D., Zhu, X., Larsen, N.A., Wilson, I.A., Xu, X., Goddard, W.A., 3rd, Janda, K.D., Eschenmoser, A., and Lerner, R.A. (2001) Antibody catalysis of the oxidation of water. Science 293, 1806-1811.
113. Wentworth, A.D., Jones, L.H., Wentworth, P., Jr., Janda, K.D., and Lerner, R.A. (2000) Antibodies have the intrinsic capacity to destroy antigens. Proc. Natl. Acad. Sci. U. S. A. 97, 10930-10935.
114. Ikhmyangan, E.N., Vasilenko, N.L., Buneva, V.N., and Nevinsky, G.A. (2005) IgG antibodies with peroxidase-like activity from the sera of healthy Wistar rats. FEBS Lett. 579, 3960-3964.
115. Ikhmyangan, E.N., Vasilenko, N.L., Buneva, V.N., and Nevinsky, G.A. (2006) Metal ions-dependent peroxidase and oxidoreductase activities of polyclonal IgGs from the sera of Wistar rats. J. Mol. Recognit. 19, 91-105.
116. Ikhmyangan, E.N., Vasilenko, N.L., Sinitsina, O.I., Buneva, V.N., and Nevinsky, G.A. (2006) Substrate specificity of rat sera IgG antibodies with peroxidase and oxidoreductase activities. J. Mol. Recognit. 19, 432-440.
117. Sun, M., Gao, Q.S., Kirnarskiy, L., Rees, A., and Paul, S. (1997) Cleavage specificity of a proteolytic antibody light chain and effects of the heavy chain variable domain. J. Mol. Biol. 271, 374-385.
118. Kanyshkova, T.G., Semenov, D.V., Khlimankov, D., Buneva, V.N., and Nevinsky, G.A. (1997) DNA-hydrolyzing activity of the light chain of IgG antibodies from milk of healthy human mothers. FEBS Lett. 416, 23-26.
119. Nevinsky, G.A., Kanyshkova, T.G., Semenov, D.V., Vlassov, A.V., Gal'vita, A.V., and Buneva, V.N. (2000) Secretory immunoglobulin A from healthy human mothers' milk catalyzes nucleic acid hydrolysis. Appl. Biochem. Biotechnol. 83, 115-129.
120. Galvita, A.V., Baranovskii, A.G., Kuznetsova, I.A., Vinshu, N.V., Galenok, V.A., Buneva, V.N., and Nevinsky, G.A. (2007) A peculiarity of DNA hydrolysis by antibodies from patients with diabetes. Russ. J. Immunol. 1, 116-131.
121. Andrievskaya, O.A., Buneva, V.N., Naumov, V.A., and Nevinsky, G.A. (2000) Catalytic heterogeneity of polyclonal RNA-hydrolyzing IgM from sera of patients with lupus erythematosus. Med. Sci. Monit. 6, 460-470.
122. Andrievskaya, O.A., Buneva, V.N., Baranovskii, A.G., Gal'vita, A.V., Benzo, E.S., Naumov, V.A., and Nevinsky, G.A. (2002) Catalytic diversity of polyclonal RNA-hydrolyzing IgG antibodies from the sera of patients with systemic lupus erythematosus. Immunol. Lett. 81, 191-198.
123. Baranovskii, A.G., Ershova, N.A., Buneva, V.N., Kanyshkova, T.G., Mogelnitskii, A.S., Doronin, B.M., Boiko, A.N., Gusev, E.I., Favorova, O.O., and Nevinsky, G.A. (2001) Catalytic heterogeneity of polyclonal DNA-hydrolyzing antibodies from the sera of patients with multiple sclerosis. Immunol. Lett. 76, 163-167.
124. Kim, J.S., Lee, S.Y., Lee, W.R., Sohn, J.N., Chung, Y.C., Shim, H.K., Lee, S.C., Kwon, M.H., and Kim, Y.S. (2006) Heavy and light chain variable single domains of an anti-DNA binding antibody hydrolyze both double- and single-stranded DNAs without sequence specificity. J. Biol. Chem. 281, 15287-15295.
125. Semenov, D.V., Kanyshkova, T.G., Karotaeva, N.A., Krasnorutskii, M.A., Kuznetsova, I.A., Buneva, V.N., and Nevinsky, G.A. (2004) Catalytic nucleotide-hydrolyzing antibodies in milk and serum of clinically healthy human mothers. Med. Sci. Monit. 10, BR23-BR33.
126. Legostaeva, G.A., Polosukhina, D.I., Bezuglova, A.M., Doronin, B.M., Buneva, V.N., and Nevinsky, G.A. (2009) Affinity and catalytic heterogeneity of polyclonal myelin basic protein-hydrolyzing IgGs from sera of patients with multiple sclerosis. J. Cell. Mol. Med. 14, 699-709.
127. Parkhomenko, T.A., Legostaeva, G.A., Doronin, B.M., Buneva, V.N., and Nevinsky, G.A. (2010) IgGs containing light chains of the lambda and kappa type and of all subclasses (IgG1-IgG4) from sera of patients with multiple sclerosis hydrolyze DNA. J. Mol. Recognit. [Epub ahead of print]
128. Buneva, V.N., Kanyshkova, T.G., Vlassov, A.V., Semenov, D.V., Khlimankov, D., Breusova, L.R., and Nevinsky, G.A. (1998) Catalytic DNA- and RNA-hydrolyzing antibodies from milk of healthy human mothers. Appl. Biochem. Biotechnol. 75, 63-76.
129. Vlassov, A.V., Andrievskaya, O.A., Kanyshkova, T.G., Baranovsky, A.G., Naumov, V.A., Breusov, A.A., Giege, R., Buneva, V.N., and Nevinsky, G.A. (1997) RNA-hydrolyzing antibodies from peripheral blood of patients with lupus erythematosus. Biochemistry (Mosc.) 62, 474-479. (Pubitemid 127588707)
130. Vlasov, A.V., Baranovskii, A.G., Kanyshkova, T.G., Prints, A.V., Zabara, V.G., Naumov, V.A., Breusov, A.A., Giege, R., Buneva, V.N., and Nevinskii, G.A. (1998) Substrate specificity of serum DNA- and RNA-hydrolyzing antibodies of patients with polyarthritis and autoimmune thyroiditis. Mol. Biol. (Mosk.) 32, 559-569.
131. Vlassov, A., Florentz, C., Helm, M., Naumov, V., Buneva, V., Nevinsky, G., and Giege, R. (1998) Characterization and selectivity of catalytic antibodies from human serum with RNAse activity. Nucleic Acids Res. 26, 5243-5250. (Pubitemid 28542720)
132. Vlassov, A.V., Helm, M., Florentz, C., Naumov, V., Breusov, A.A., Buneva, V.N., Giege, R., and Nevinsky, G.A. (1999) Variability of substrate specificity of serum antibodies obtained from patients with different autoimmune and viral deseases in reaction of tRNA hydrolysis Russ. J. Immunol. 4, 25-32.
133. Vlasov, A.V., Helm, M., Naumov, V.A., Breusov, A.A., Buneva, V.N., Florentz, C., Giege, R., and Nevinskii, G.A. (1999) Features of tRNA hydrolysis by autoantibodies from blood serum of patients with certain autoimmune and virus diseases. Mol. Biol. (Mosk.) 33, 866-872.
134. Andrievskaia, O.A., Kanyshkova, T.G., Iamkovoi, V.I., Buneva, V.N., and Nevinskii, G.A. (1997) Monoclonal antibodies to DNA hydrolyze RNA better than DNA. Dokl. Akad. Nauk 355, 401-403.
135. Gololobov, G.V., Chernova, E.A., Schourov, D.V., Smirnov, I.V., Kudelina, I.A., and Gabibov, A.G. (1995) Cleavage of supercoiled plasmid DNA by autoantibody Fab fragment: application of the flow linear dichroism technique. Proc. Natl. Acad. Sci. U. S. A. 92, 254-257.
136. Kuznetsova, I.A., Orlovskaya, I.A., Buneva, V.N., and Nevinsky, G.A. (2007) Activation of DNA-hydrolyzing antibodies from the sera of autoimmune-prone MRL-lpr/lpr mice by different metal ions. Biochim. Biophys. Acta 1774, 884-896.
137. Kit, Y.Ya., Semenov, D.V., and Nevinsky, G.A. (1996) Phosphorylation of different human milk proteins by human catalytic secretory immunoglobulin A. Biochem. Mol. Biol. Int. 39, 521-527.
138. Nevinsky, G.A., Kit, Y., Semenov, D.V., Khlimankov, D., and Buneva, V.N. (1998) Secretory immunoglobulin A from human milk catalyses milk protein phosphorylation. Appl. Biochem. Biotechnol. 75, 77-91.
139. Gorbunov, D.V., Semenov, D.V., Shipitsin, M.V., Kit, Y.Ya., Kanyshkova, T.G., Buneva, V.N., and Nevinsky, G.A. (2000) Phosphorylation of minor lipids of human milk tightly bound to secretory immunoglobulin A. Russ. J. Immunol. 5, 267-278.
140. Gorbunov, D.V., Karataeva, N.A., Buneva, V.N., and Nevinsky, G.A. (2005) Lipid kinase activity of antibodies from milk of clinically healthy human mothers. Biochim. Biophys. Acta 1735, 153-166.
141. Karataeva, N.A., Gorbunov, D., Prokudin, I.V., Buneva, V.N., Kulminskaya, A.A., Neustroev, K.N., and Nevinsky, G.A. (2006) Human milk antibodies with polysaccharide kinase activity. Immunol. Lett. 103, 58-67.
142. Karataeva, N.A., Buneva, V.N., and Nevinsky, G.A. (2006) Polysaccharide kinase activity of human milk IgG antibodies. Biochemistry (Mosc.) 71, 1488-1504.
143. Baranovskii, A.G., Matushin, V.G., Vlassov, A.V., Zabara, V.G., Naumov, V.A., Buneva, V.N., and Nevinskii, G.A. (1997) DNA- and RNA-hydrolyzing antibodies from the blood of patients with various forms of viral hepatitis. Biochemistry (Mosc.), 62, 1358-1366.
144. Baranovskii, A.G., Kanyshkova, T.G., Mogelnitskii, A.S., Naumov, V.A., Buneva, V.N., Gusev, E.I., Boiko, A.N., Zargarova, T.A., Favorova, O.O., and Nevinsky, G.A. (1998) Polyclonal antibodies from blood and cerebrospinal fluid of patients with multiple sclerosis effectively hydrolyze DNA and RNA. Biochemistry (Mosc.) 63, 1239-1248.
145. Paul, S., Mei, S., Mody, B., Eklund, S.H., Beach, C.M., Massey, R.J., and Hamel, F. (1991) Cleavage of vasoactive intestinal peptide at multiple sites by autoantibodies. J. Biol. Chem. 266, 16128-16134.
146. Paul, S., Karle, S., Planque, S., Taguchi, H., Salas, M., Nishiyama, Y., Handy, B., Hunter, R., Edmundson, A., and Hanson, C. (2004) Naturally occurring proteolytic antibodies: selective immunoglobulin M-catalyzed hydrolysis of HIV gp120. J. Biol. Chem. 279, 39611-39619.
147. Savel'ev, A.N., Kanyshkova, T.G., Kulminskaya, A.A., Buneva, V.N., Eneyskaya, E.V., Filatov, M.V., Nevinsky, G.A., and Neustroev, K.N. (2001) Amylolytic activity of IgG and sIgA immunoglobulins from human milk. Clin. Chim. Acta 314, 141-152.
148. Savel'ev, A.N., Eneyskaya, E.V., Shabalin, K.A., Filatov, M.V., and Shabalin, K.A. (1999) Autoantibodies with amylolytic activity. Prot. Pept. Lett. 6, 179-184.
149. Ivanen, D.R., Kulminskaya, A.A., Shabalin, K.A., Isaeva-Ivanova, L.V., Ershova, N.A., Saveliev, A.N., Nevinsky, G.A., and Neustroev, K.N. (2004) Catalytic properties of IgMs with amylolytic activity isolated from patients with multiple sclerosis. Med. Sci. Monit. 10, BR273-BR280.
150. Neustoev, K.N., Ivanen, D.R., Kulminskaya, A.A., Brumer, I.H., Saveliev, A.N., and Nevinsky, G.A. (2003) Amylolytic activity and catalytic properties of IgM and IgG antibodies from patients with systemic lupus erythematosus. Hum. Antibodies 12, 31-34.
151. Savel'iev, A.N., Ivanen, D.R., Kulminskaya, A.A., Ershova, N.A., Kanyshkova, T.G., Buneva, V.N., Mogelnitskii, A.S., Doronin, B.M., Favorova, O.O., Nevinsky, G.A., and Neustroev, K. (2003) Amylolytic activity of IgM and IgG antibodies from patients with multiple sclerosis. Immunol. Lett. 86, 291-297.
152. Odintsova, E.S., Zaksas, N.P., Buneva, V.N., and Nevinsky, G.A. (2010) Metal dependent hydrolysis of beta-casein by sIgA antibodies from human milk. J. Mol. Recognit. [Epub ahead of print]
153. Andrievskaia, O.A., Buneva, V.N., Zabara, V.G., Naumov, V.A., Iamkovoi, V.I., and Nevinskii, G.A. (1998) Class M immunoglobulins from blood serum of patients with systemic lupus erythematosus effectively cleave RNA. Mol. Biol. (Mosk.) 32, 908-915.
154. Tellier, C. (2002) Exploiting antibodies as catalysts: potential therapeutic applications. Transfus. Clin. Biol. 9, 1-8.
155. Zhou, Y.X., Karle, S., Taguchi, H., Planque, S., Nishiyama, Y., and Paul, S. (2002) Prospects for immunotherapeutic proteolytic antibodies. J. Immunol. Methods 269, 257-268.
156. Nishi, Y. (2003) Enzyme/abzyme prodrug activation systems: potential use in clinical oncology. Curr. Pharm. Des. 9, 2113-2130.
157. Stockwin, L.H. and Holmes, S. (2003) Antibodies as therapeutic agents: vive la renaissance! Expert Opin. Biol. Ther. 3, 1133-1152.
158. Hanson, C.V., Nishiyama, Y., and Paul, S. (2005) Catalytic antibodies and their applications. Curr. Opin. Biotechnol. 16, 631-636.
159. Gabibov, A.G., Ponomarenko, N.A., Tretyak, E.B., Paltsev, M.A., and Suchkov, S.V. (2006) Catalytic autoantibodies in clinical autoimmunity and modern medicine. Autoimmun. Rev. 5, 324-330.
160. Planque, S., Nishiyama, Y., Taguchi, H., Salas, M., Hanson, C., and Paul, S. (2008) Catalytic antibodies to HIV: physiological role and potential clinical utility. Autoimmun. Rev. 7, 473-479.
161. Wójcik, T. and Kieć-Kononowicz, K. (2008) Catalytic activity of certain antibodies as a potential tool for drug synthesis and for directed prodrug therapies. Curr. Med. Chem. 15, 1606-1615.
162. De Prada, P., Winger, G., and Landry, D.W. (2000) Application of artificial enzymes to the problem of cocaine. Ann. N. Y. Acad. Sci. 909, 159-169.
163. Wootla, B., Dasgupta, S., Mallet, V., Kazatchkine, M.D., Nagaraja, V., Friboulet, A., Kaveri, S.V., and Lacroix- Desmazes, S. (2006) Physiopathology of catalytic antibodies: the case for factor VIII-hydrolyzing immunoglobulin G. Blood Coagul. Fibrinolysis 17, 229-234. (Pubitemid 43756116)
164. Lacroix-Desmazes, S., Kazatchkine, M.D., and Kaveri, S.V. (2003) Catalytic antibodies to factor VIII in haemophilia A. Blood Coagul. Fibrinolysis 14(Suppl. 1), S31-S34.
165. Bayry, J., Lacroix-Desmazes, S., Pashov, A., Stahl, D., Hoebeke, J., Kazatchkine, M.D., and Kaveri, S.V. (2003) Autoantibodies to factor VIII with catalytic activity. Autoimmun. Rev. 2, 30-35.
166. Lacroix-Desmazes, S., Wootla, B., Delignat, S., Dasgupta, S., Nagaraja, V., Kazatchkine, M.D., and Kaveri, S.V. (2006) Pathophysiology of catalytic antibodies. Immunol. Lett. 103, 3-7.
167. Taizo, U., Hifumi, E., and Okamura, Y. (2006) Super catalytic antibodies (antigenase) capable of destroying H. pylori urease. Nippon Rinsho 64, 286-292.
168. Tguchi, H., Planque, S., Nishiyama, Y., Szabo, P., and Weksler, M.E. (2008) Catalytic antibodies to amyloid beta peptide in defense against Alzheimer disease. Autoimmun. Rev. 7, 391-397.